本页面由Tiger Trade Technology Pte. Ltd.提供服务

Theravance Biopharma Inc.

17.03
0.0000
成交量:- -
成交额:- -
市值:8.83亿
市盈率:16.30
高:17.03
开:17.03
低:17.03
收:17.03
52周最高:21.03
52周最低:13.08
股本:5,182.83万
流通股本:2,585.69万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):1.05
每股收益(LYR):2.06
净资产收益率:20.91%
总资产收益率:1.33%
市净率:3.05
市盈率(LYR):8.27

数据加载中...

2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/24

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/09/23

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/09/23

重要事件披露

Form 8-K - Current report
2026/09/18

重要事件披露

Form 8-K - Current report
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/10

重要事件披露

Form 8-K - Current report
2026/08/25

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report